Abstract:Background: Panax notoginseng saponins (PNS) extracted from the roots of panax notoginseng are free radical-scavenger, with an antioxidant property, capable of inhibiting expression of adhesion molecules and chemokines. This study was designed to test the effects of PNS administration in apolipoprotein (apo)-E-deficient mice on the activation of JNK, p38(MAPK), ERK1/2 and NF-kappa B, and the expression of RAGE, adhesion molecules and chemokines in the atherosclerotic lesions. Methods: Wild type and apoE-null mice ( male, 10-week-old) were treated with PNS for 4 weeks. Peripheral blood was collected for assessing the serum levels of glucose, lipids and MDA, and activities of SOD and GSH. The sizes of atherosclerotic lesions and numbers of macrophages in the branchiocephalic arteries, and the reactive oxygen species (ROS) production in the aortic root were analyzed. The levels of CD68, Galectin-3, RAGE, JNK, phosphor-JNK, p38(MAPK), phosphor-p38(MAPK), ERK1/2, phosphor-ERK1/2, I-kappa B, phosphor-I-kappa B (Ser32), NF-kappa B, phosphor-NF-kappa B, MCP-1, VCAM-1 and ICAM-1 in the descending arteries were identified by Western blot. Results: The atherosclerotic lesion sizes, and macrophage numbers, but not the smooth muscle cell amounts and the collagen content, were decreased in apoE(-/-)mice treated with PNS. After PNS administration for 4 weeks, the apoE(-/-) mice displayed reduced level of serum MDA and enhanced activity of SOD and GSH, accompanied by impaired ROS generation in the aortic root. Moreover, PNS down-regulated the expression of VCAM-1, ICAM-1 and MCP-1, accompanied by reduced expression of RAGE and suppressed the activation of NF-kappa B, JNK, p38(MAPK) and ERK1/2. Conclusion: PNS may inhibit progression of atherosclerotic lesions via their antioxidant/anti-inflammatory biological properties. PNS suppress the RAGE/MAPK signaling pathways, inactivate NF-kappa B, and reduce expression of pro-inflammatory factors, such as VCAM-1, ICAM-1 and MCP-1 in atherosclerotic lesions of apoE(-/-) mice. Copyright (c) 2012 S. Karger AG, Basel

Ginsenoside-Rd, A Purified Component from Panax Notoginseng Saponins, Prevents Atherosclerosis in Apoe Knockout Mice

Panax Notoginseng Saponins Inhibits Atherosclerotic Plaque Angiogenesis by Down-Regulating Vascular Endothelial Growth Factor and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Subunit 4 Expression.

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic Aldehyde Reduces Atherosclerosis and Attenuates Low-Shear Stress-Induced Vascular Endothelial Cell Dysfunction

Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF

Ginsenoside Rb-1 Enhances Plaque Stability And Inhibits Adventitial Vasa Vasorum Via The Modulation Of Mir-33 And Pedf

The Hydrogen Sulfide Donor, Gyy4137, Exhibits Anti-Atherosclerotic Activity in High Fat Fed Apolipoprotein E-/- Mice

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model.

Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.

20(S)-protopanaxadiol decreases atherosclerosis in the ApoE KO mice by increasing the levels of LDLR and inhibiting its binding with PCSK9

Ginsenoside-Rd from Panax Notoginseng Blocks Ca2+ Influx Through Receptor- and Store-Operated Ca2+ Channels in Vascular Smooth Muscle Cells.

Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis

Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE−/− Mice by Regulating PPARγ/FAK Signaling Pathway

Ginsenoside Rb1 Enhances Atherosclerotic Plaque Stability by Improving Autophagy and Lipid Metabolism in Macrophage Foam Cells

Total Panax Notoginsenosides Prevent Atherosclerosis in Apolipoprotein E-knockout Mice: Role of Downregulation of CD40 and MMP-9 Expression.

Notoginsenoside R1-Protocatechuic Aldehyde Reduces Vascular Inflammation and Calcification Through Increasing the Release of Nitric Oxide to Inhibit TGFβR1-YAP/TAZ Pathway in Vascular Smooth Muscle Cells

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic aldehyde attenuates low shear stress-induced vascular endothelial cell dysfunction

Panax Notogingseng Saponins Suppress Rage/Mapk Signaling and Nf-Kappab Activation in Apolipoprotein-E-Deficient Atherosclerosis-Prone Mice

Ginsenoside Rg3 Mitigates Atherosclerosis Progression in Diabetic apoE–/– Mice by Skewing Macrophages to the M2 Phenotype

Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis

Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.

Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype